| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-409X(02)00050-9 |
| P698 | PubMed publication ID | 12384314 |
| P50 | author | Abraham Domb | Q24038323 |
| P2093 | author name string | Robert S Langer | |
| Neeraj Kumar | |||
| P2860 | cites work | Polyanhydrides. I. Preparation of high molecular weight polyanhydrides | Q57923278 |
| Double-walled polymer microspheres for controlled drug release | Q59089415 | ||
| Poly(fumaric–co-sebacic anhydride) | Q60150573 | ||
| Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity | Q62132710 | ||
| Polyanhydride microsphere formulation by solvent extraction | Q68002867 | ||
| Controlled delivery systems for proteins using polyanhydride microspheres | Q70684838 | ||
| Controlled release of macromolecules from a degradable polyanhydride matrix | Q71660903 | ||
| Bioerodible polyanhydrides for controlled drug delivery | Q71760256 | ||
| Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone | Q73172675 | ||
| Investigation of the in vitro release of gentamicin from a polyanhydride matrix | Q73280986 | ||
| Polymeric systems for controlled drug release | Q77367258 | ||
| Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics | Q77915621 | ||
| Ricinoleic acid-based biopolymers | Q77975680 | ||
| Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems | Q81646893 | ||
| Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery | Q32050099 | ||
| In vitro/in vivo comparison of drug release and polymer erosion from biodegradable P(FAD-SA) polyanhydrides--a noninvasive approach by the combined use of electron paramagnetic resonance spectroscopy and nuclear magnetic resonance imaging. | Q36869084 | ||
| Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation. | Q38548436 | ||
| Gamma-sterilization-induced radicals in biodegradable drug delivery systems. | Q38559480 | ||
| Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. | Q38559786 | ||
| Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy | Q38561506 | ||
| The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial | Q38562276 | ||
| Prolonged regional nerve blockade by controlled release of local anesthetic from a biodegradable polymer matrix. | Q38566912 | ||
| Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain | Q38567539 | ||
| Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain | Q38570954 | ||
| Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. | Q38571909 | ||
| Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. | Q39305161 | ||
| Polyanhydrides for controlled release of bioactive agents | Q39797794 | ||
| Brain biocompatibility of a biodegradable, controlled-release polymer in rats | Q39846989 | ||
| Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders | Q41264952 | ||
| The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. | Q42011060 | ||
| Gamma-irradiation stability of saturated and unsaturated aliphatic polyanhydrides--ricinoleic acid based polymers. | Q43800303 | ||
| Nonlinear fatty acid terminated polyanhydrides. | Q43827437 | ||
| Stereocomplexes of enantiomeric lactic acid and sebacic acid ester-anhydride triblock copolymers. | Q44051480 | ||
| Polymer chemotherapy for head and neck cancer. | Q44563148 | ||
| Sterilization, storage stability and in vivo biocompatibility of poly(trimethylene carbonate)/poly(adipic anhydride) blends | Q44813503 | ||
| Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas | Q45325311 | ||
| The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers | Q46802173 | ||
| Photopolymers in orthopedics: characterization of novel crosslinked polyanhydrides. | Q50511997 | ||
| Sustained local anesthetic release from bioerodible polymer matrices: a potential method for prolonged regional anesthesia. | Q51653872 | ||
| FTIR-ATR spectroscopy for monitoring polyanhydride/anhydride-amine reactions. | Q52071886 | ||
| Surface modification of polyanhydride microspheres | Q57189227 | ||
| Fatty acid terminated polyanhydrides | Q57922599 | ||
| Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury | Q57922611 | ||
| Surface Analysis of Biodegradable Polymer Blends of Poly(sebacic anhydride) and Poly(dl-lactic acid) | Q57922825 | ||
| Biodegradable polymers derived from natural fatty acids | Q57922844 | ||
| In vivo and in vitro elimination of aliphatic polyanhydrides | Q57922876 | ||
| Absorbable biopolymers derived from dimer fatty acids | Q57922986 | ||
| Bioerodible polyanhydrides for antibiotic drug delivery: In vivo osteomyelitis treatment in a rat model system | Q57922999 | ||
| Degradable polymer blends. I. Screening of miscible polymers | Q57923012 | ||
| Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid | Q57923023 | ||
| Synthesis and characterization of biodegradable aromatic anhydride copolymers | Q57923039 | ||
| NMR characterization of erodible copolymers | Q57923053 | ||
| Polyanhydrides. IV. Unsaturated and crosslinked polyanhydrides | Q57923063 | ||
| The analysis of the surface chemical structure of biomedical aliphatic polyanhydrides using XPS and ToF-SIMS | Q57923076 | ||
| The application of Fourier transform Raman spectroscopy to the analysis of poly(anhydride) homo- and co-polymers | Q57923091 | ||
| Biodegradable polymers derived from amino acids | Q57923102 | ||
| PolyanhydridesV. Branched polyanhydrides | Q57923151 | ||
| Poly(anhydrides). 3. Poly(anhydrides) based on aliphatic-aromatic diacids | Q57923188 | ||
| Solid-state and solution stability of poly(anhydrides) and poly(esters) | Q57923200 | ||
| Poly(anhydrides). 2. One-step polymerization using phosgene or diphosgene as coupling agents | Q57923214 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 889-910 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Polyanhydrides: an overview | |
| P478 | volume | 54 |
| Q35047038 | A Versatile Monomer for Preparing Well-Defined Functional Polycarbonates and Poly(ester-carbonates) |
| Q34364393 | Antibiotic-containing polymers for localized, sustained drug delivery |
| Q46219988 | Biocompatibility evaluation of N,O-hexanoyl chitosan as a biodegradable hydrophobic polycation for controlled drug release |
| Q41382718 | Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage |
| Q50325324 | Biodegradable Polymers. |
| Q38131659 | Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. |
| Q37429043 | Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. |
| Q37002674 | Biodegradable polymers for microencapsulation of drugs. |
| Q57920810 | Biodegradable polymers-an overview |
| Q37362564 | Bioerodible system for sequential release of multiple drugs |
| Q58484641 | Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications |
| Q42114702 | Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells |
| Q50976330 | Characterization and in vitro degradation of poly(octadecanoic anhydride). |
| Q37399847 | Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters). |
| Q36316931 | Current advances in sustained-release systems for parenteral drug delivery |
| Q37403010 | Degradability of polymers for implantable biomedical devices |
| Q33902253 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. |
| Q37278887 | Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts |
| Q92444845 | Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications |
| Q33635797 | Design and Synthesis of Fast-Degrading Poly(anhydride-esters). |
| Q41990578 | Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function |
| Q37890406 | Drug delivery in soft tissue engineering |
| Q30379368 | Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres |
| Q35883773 | Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility |
| Q35193102 | Enhanced blood compatibility of metallocene polyethylene subjected to hydrochloric acid treatment for cardiovascular implants. |
| Q37442003 | Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo |
| Q35946494 | Enzymatic Polymerization of an Ibuprofen-Containing Monomer and Subsequent Drug Release |
| Q46989472 | Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery |
| Q39279197 | Evaluation of poly (1, 6-bis-(p-carboxyphenoxy) hexane-co-sebacic acid microspheres for controlled basal insulin delivery |
| Q57423738 | Hydrolytically Sensitive Fiber-Forming Bioresorbable Polymers |
| Q35353651 | In Vitro Degradation of an Aromatic Polyanhydride with Enhanced Thermal Properties |
| Q41556936 | Intramolecular Cyclization for Stimuli-Controlled Depolymerization of Polycaprolactone Particles Leading to Disassembly and Payload Release |
| Q37640704 | Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model |
| Q47292447 | Investigating the effects of surfactants on the size and hydrolytic stability of poly(adipic anhydride) particles |
| Q53593544 | Materials, designs, and operational characteristics for fully biodegradable primary batteries. |
| Q35609775 | Microspheres for controlled release drug delivery |
| Q26823541 | Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery |
| Q37153923 | Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues |
| Q38261634 | Multistep, effective drug distribution within solid tumors. |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q37043977 | Novel 4-arm poly(ethylene glycol)-block-poly(anhydride-esters) amphiphilic copolymer micelles loading curcumin: preparation, characterization, and in vitro evaluation |
| Q58993103 | Paclitaxel Release from Polyether-Anhydrides Prepared with UV-Curing Process |
| Q57346515 | Poly(Lactic Acid) Blends |
| Q35902758 | Polyactives: controlled and sustained bioactive release via hydrolytic degradation |
| Q42174370 | Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases |
| Q37065943 | Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances |
| Q58436049 | Polymeric Materials in Ocular Drug Delivery Systems |
| Q37739481 | Polymeric drug delivery systems for localized cancer chemotherapy |
| Q47855032 | Preparation and characterization of protein-loaded polyanhydride microspheres |
| Q57921065 | Preparation and in vitro characterization of poly(sebacic acid-co-ricinoleic acid)-based tamoxifen citrate-loaded microparticles for breast cancer |
| Q57428332 | Printing amphotericin B on microneedles using matrix assisted pulsed laser evaporation |
| Q42812415 | Quantitative and qualitative toxicological evaluation of thiol-ene "click" chemistry-based polyanhydrides and their degradation products |
| Q41232611 | Reaction-diffusion degradation model for delayed erosion of cross-linked polyanhydride biomaterials |
| Q37719553 | Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers |
| Q38029806 | Recent advances in polymeric microspheres for parenteral drug delivery--part 1. |
| Q38689914 | Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview |
| Q36625252 | Recent developments in biodegradable synthetic polymers |
| Q37184497 | Recent developments in cyclic acetal biomaterials for tissue engineering applications |
| Q36903816 | Review on Medusa:a polymer-based sustained release technology for protein and peptide drugs |
| Q37184228 | Silicon micro- and nanofabrication for medicine |
| Q50928936 | Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. |
| Q90696345 | Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague |
| Q38221776 | Smart chemistry in polymeric nanomedicine. |
| Q57367351 | Sol–gel transition of PEG–PAF aqueous solution and its application for hGH sustained release |
| Q34382860 | Storage Stability Study of Salicylate-based Poly(anhydride-esters) |
| Q41866695 | Synthesis and Characterization of 5-Aminosalicylic Acid Based Poly(anhydride-esters) by Solution Polymerization |
| Q34078236 | Synthesis and self-assembly behavior of a biodegradable and sustainable soybean oil-based copolymer nanomicelle |
| Q38722460 | The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response |
| Q38861017 | Toward Understanding Drug Release From Biodegradable Polymer Microspheres of Different Erosion Kinetics Modes |
| Q34041600 | Tuning hydrogel properties and function using substituent effects. |
| Q47395714 | Unlocking the Potential of Poly(Ortho Ester)s: A General Catalytic Approach to the Synthesis of Surface-Erodible Materials |
Search more.